Marco Gerlinger

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Venues

Nature biomedical engineering

Nature communications

Journal for immunotherapy of cancer

The Journal of pathology

Institute of Cancer Research

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institute of Cancer Research Oct 22 2013

United Kingdom

Group Leader :: Centre for Evolution and Cancer

Publications

Marta Buzzetti, Marco Gerlinger
Assessing the toxicity of bispecific antibodies. Nature biomedical engineering 8 (4) (2024)
Marta Buzzetti, Marco Gerlinger
Assessing the toxicity of bispecific antibodies. Nature biomedical engineering 8 (4) (2024)
Marta Buzzetti, Marco Gerlinger
Assessing the toxicity of bispecific antibodies. Nature biomedical engineering (2023)
Alice Newey, Lu Yu, Louise J Barber, Jyoti Sharma Choudhary, Michal Bassani-Sternberg, Marco Gerlinger
Multifactorial Remodeling of the Cancer Immunopeptidome by IFNγ. Cancer research communications 3 (11) (2023)
Benjamin R Challoner, Andrew Woolston, David Lau, Marta Buzzetti, Caroline Fong, Louise J Barber, Gayathri Anandappa, Richard Crux, Ioannis Assiotis, Kerry Fenwick, Ruwaida Begum, Dipa Begum, Tom Lund, Nanna Sivamanoharan, Harold B Sansano, Melissa Domingo-Arada, Amina Tran, Hardev Pandha, David N Church, Bryony Eccles, Richard Ellis, Stephen Falk, Mark Hill, Daniel Krell, Nirupa Murugaesu, Luke Nolan, Vanessa Potter, Mark Saunders, Kai-Keen Shiu, Sebastian Guettler, James L Alexander, Héctor Lázare-Iglesias, James Kinross, Jamie Murphy, Katharina von Loga, David Cunningham, Ian Chau, Naureen Starling, Juan Ruiz-Bañobre, Tony Dhillon, Marco Gerlinger
Genetic and immune landscape evolution in MMR-deficient colorectal cancer. The Journal of pathology (2023)
Andrew Woolston, Louise J Barber, Beatrice Griffiths, Oriol Pich, Nuria Lopez-Bigas, Nik Matthews, Sheela Rao, David Watkins, Ian Chau, Naureen Starling, David Cunningham, Marco Gerlinger
Mutational signatures impact the evolution of anti-EGFR antibody resistance in colorectal cancer. Nature ecology & evolution 5 (7) (2021)
Katharina von Loga, Andrew Woolston, Marco Punta, Louise J Barber, Beatrice Griffiths, Maria Semiannikova, Georgia Spain, Benjamin R Challoner, Kerry Fenwick, Ronald Simon, Andreas Marx, Guido Sauter, Stefano Lise, Nik Matthews, Marco Gerlinger
Author Correction: Extreme intratumour heterogeneity and driver evolution in mismatch repair deficient gastro-oesophageal cancer. Nature communications 11 (1) (2020)
Franciele H Knebel, Louise J Barber, Alice Newey, Dimitrios Kleftogiannis, Andrew Woolston, Beatrice Griffiths, Kerry Fenwick, Fabiana Bettoni, Maurício Fernando Silva Almeida Ribeiro, Leonardo da Fonseca, Frederico Costa, Fernanda Cunha Capareli, Paulo M Hoff, Jorge Sabbaga, Anamaria Aranha Camargo, Marco Gerlinger
Circulating Tumour DNA Sequencing Identifies a Genetic Resistance-Gap in Colorectal Cancers with Acquired Resistance to EGFR-Antibodies and Chemotherapy. Cancers 12 (12) (2020)
Katharina von Loga, Andrew Woolston, Marco Punta, Louise J Barber, Beatrice Griffiths, Maria Semiannikova, Georgia Spain, Benjamin R Challoner, Kerry Fenwick, Ronald Simon, Andreas Marx, Guido Sauter, Stefano Lise, Nik Matthews, Marco Gerlinger
Extreme intratumour heterogeneity and driver evolution in mismatch repair deficient gastro-oesophageal cancer. Nature communications 11 (1) (2020)
Alice Newey, Beatrice Griffiths, Justine Michaux, Hui Song Pak, Brian J Stevenson, Andrew Woolston, Maria Semiannikova, Georgia Spain, Louise J Barber, Nik Matthews, Sheela Rao, David Watkins, Ian Chau, George Coukos, Julien Racle, David Gfeller, Naureen Starling, David Cunningham, Michal Bassani-Sternberg, Marco Gerlinger
Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment. Journal for immunotherapy of cancer 7 (1) (2019)
Reyes Gonzalez-Exposito, Maria Semiannikova, Beatrice Griffiths, Khurum Khan, Louise J Barber, Andrew Woolston, Georgia Spain, Katharina von Loga, Ben Challoner, Radhika Patel, Michael Ranes, Amanda Swain, Janet Thomas, Annette Bryant, Claire Saffery, Nicos Fotiadis, Sebastian Guettler, David Mansfield, Alan Melcher, Thomas Powles, Sheela Rao, David Watkins, Ian Chau, Nik Matthews, Fredrik Wallberg, Naureen Starling, David Cunningham, Marco Gerlinger
CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids. Journal for immunotherapy of cancer 7 (1) (2019)

Marco Gerlinger.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Marco Gerlinger